2.1(top 20%)
impact factor
1.5K(top 20%)
papers
25.1K(top 10%)
citations
60(top 10%)
h-index
2.5(top 20%)
extended IF
2.0K
all documents
28.1K
doc citations
86(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Has the time come for a staging model to map the course of eating disorders from high risk to severe enduring illness? An examination of the evidenceMicrobial Biotechnology2015254
2Social media and suicide prevention: a systematic reviewMicrobial Biotechnology2016228
3Age at onset and the outcomes of schizophrenia: A systematic review and meta‐analysisMicrobial Biotechnology2017207
4Review of the operational definition for first‐episode psychosisMicrobial Biotechnology2009202
5Evaluating an individualized lifestyle and life skills intervention to prevent antipsychotic‐induced weight gain in first‐episode psychosisMicrobial Biotechnology2016181
6Applying clinical staging to young people who present for mental health careMicrobial Biotechnology2013180
7The effectiveness of school mental health literacy programs to address knowledge, attitudes and help seeking among youthMicrobial Biotechnology2013178
8Prevention and early intervention to improve mental health in higher education students: a reviewMicrobial Biotechnology2010175
9Resilience as a multimodal dynamic processMicrobial Biotechnology2019162
10Beliefs about appropriate first aid for young people with mental disorders: findings from an Australian national survey of youth and parentsMicrobial Biotechnology2007155
11Mental health literacy in higher education studentsMicrobial Biotechnology2012153
12Australia's innovation in youth mental health care: The headspace centre modelMicrobial Biotechnology2019150
13Mental Health First Aid: an international programme for early interventionMicrobial Biotechnology2008146
14Antipsychotic‐induced weight gain in first‐episode psychosis patients: a meta‐analysis of differential effects of antipsychotic medicationsMicrobial Biotechnology2016138
15Epidemiological factors associated with treated incidence of first‐episode non‐affective psychosis in Cantabria: insights from the Clinical Programme on Early Phases of PsychosisMicrobial Biotechnology2008131
16Cognitive remediation in schizophrenia: efficacy and effectiveness in patients with early versus long‐term course of illnessMicrobial Biotechnology2014129
17Youth at ultra high risk for psychosis: using the Revised Network Episode Model to examine pathways to mental health careMicrobial Biotechnology2013128
18Role of social media and the Internet in pathways to care for adolescents and young adults with psychotic disorders and non‐psychotic mood disordersMicrobial Biotechnology2017127
19Stigma and treatment delay in first‐episode psychosis: a grounded theory studyMicrobial Biotechnology2010122
20Providing online support for young people with mental health difficulties: challenges and opportunities exploredMicrobial Biotechnology2008116
21Children's experiences of parental mental illness: a literature reviewMicrobial Biotechnology2011116
22Parent and family factors associated with service use by young people with mental health problems: a systematic reviewMicrobial Biotechnology2015105
23Moderated online social therapy for depression relapse prevention in young people: pilot study of a ‘next generation’ online interventionMicrobial Biotechnology2018104
24The First‐Episode Psychosis Outcome Study: premorbid and baseline characteristics of an epidemiological cohort of 661 first‐episode psychosis patientsMicrobial Biotechnology2007102
25Treatment and Early Intervention in Psychosis Program (TIPP‐Lausanne): implementation of an early intervention programme for psychosis in SwitzerlandMicrobial Biotechnology201398
26Pilot study of a mindfulness‐based, multi‐component, in‐school group sleep intervention in adolescent girlsMicrobial Biotechnology201397
27Early traumatic experiences in those at clinical high risk for psychosisMicrobial Biotechnology201396
28Exercise as an intervention for first‐episode psychosis: a feasibility studyMicrobial Biotechnology201896
29Trajectory to a first episode of psychosis: a qualitative research study with familiesMicrobial Biotechnology200793
30Early identification and treatment of eating disorders: prodrome to syndromeMicrobial Biotechnology200792
31A descriptive review of qualitative studies in first episode psychosisMicrobial Biotechnology201091
32Substance use in clinical high risk for psychosis: a review of the literatureMicrobial Biotechnology201487
33Role of inflammation in the pathogenesis of schizophrenia: A review of the evidence, proposed mechanisms and implications for treatmentMicrobial Biotechnology202087
34The heart of the matter: cardiometabolic care in youth with psychosisMicrobial Biotechnology201286
35The arrival of preemptive psychiatryMicrobial Biotechnology200784
36Exploring opportunities to support mental health care using social media: A survey of social media users with mental illnessMicrobial Biotechnology201984
37A systematic review on definitions and assessments of psychotic‐like experiencesMicrobial Biotechnology201682
38From research to practice: how OPUS treatment was accepted and implemented throughout DenmarkMicrobial Biotechnology201581
39Effectiveness of individual placement and support supported employment for young adultsMicrobial Biotechnology201681
40Can an Internet‐based intervention reduce suicidal ideation, depression and hopelessness among secondary school students: results from a pilot studyMicrobial Biotechnology201681
41Young people's views of UK mental health servicesMicrobial Biotechnology201480
42Broad clinical high‐risk mental state (CHARMS): Methodology of a cohort study validating criteria for pluripotent riskMicrobial Biotechnology201979
43Psychosis risk screening in different populations using the Prodromal Questionnaire: A systematic reviewMicrobial Biotechnology201878
44Mental health literacy programs for school teachers: A systematic review and narrative synthesisMicrobial Biotechnology202076
45Clinical benefits and impact of early use of long‐acting injectable antipsychotics for schizophreniaMicrobial Biotechnology201675
46Stigma in families of individuals in early stages of psychotic illness: family stigma and early psychosisMicrobial Biotechnology200972
47Global research priorities for youth mental healthMicrobial Biotechnology202072
48Canadian response to need for transformation of youth mental health services: ACCESS Open Minds (Esprits ouverts)Microbial Biotechnology201971
49Defining, operationalizing and measuring the duration of untreated psychosis: advances, limitations and future directionsMicrobial Biotechnology200769
50Social cognition deficits and the ‘ultra high risk’ for psychosis population: a review of literatureMicrobial Biotechnology201169